APO Research
Talk to an analyst

APO RESEARCH · REPORT

Next Generation AntiVirus

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Next Generation AntiVirus Market Outlook and Growth Opportunities 2026

6 January 2026199 pages

Choose your research edition.

Industry ResearchNext Generation AntiVirus Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Next Generation AntiVirus Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Next Generation AntiVirus Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Next Generation AntiVirus Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Next Generation AntiVirus Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Next Generation AntiVirus market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Next Generation AntiVirus is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Next Generation AntiVirus is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Next Generation AntiVirus is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Next Generation AntiVirus market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Next Generation AntiVirus market include Microsoft, CrowdStrike, Trend Micro, Trellix, Palo Alto Networks, Broadcom, Sophos, Bitdefender and Cisco, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Next Generation AntiVirus market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Next Generation AntiVirus and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Next Generation AntiVirus revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Next Generation AntiVirus market.

Next Generation AntiVirus Segment by Company

Microsoft

CrowdStrike

Trend Micro

Trellix

Palo Alto Networks

Broadcom

Sophos

Bitdefender

Cisco

VMware Carbon Black

Check Point

Malwarebytes

Fortinet

BlackBerry Cylance

Next Generation AntiVirus Segment by Type

Behavior and Event-Driven

AI-Driven

Others

Next Generation AntiVirus Segment by Application

Finance and Insurance

Manufacturing

Internet and High Technology

Others

Next Generation AntiVirus Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Next Generation AntiVirus status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Next Generation AntiVirus key companies, revenue, market share, and recent developments.

3. To split the Next Generation AntiVirus breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Next Generation AntiVirus market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Next Generation AntiVirus significant trends, drivers, influence factors in global and regions.

6. To analyze Next Generation AntiVirus competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Next Generation AntiVirus market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Next Generation AntiVirus and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Next Generation AntiVirus.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Next Generation AntiVirus industry.

Chapter 3: Detailed analysis of Next Generation AntiVirus company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Next Generation AntiVirus in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Next Generation AntiVirus in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Next Generation AntiVirus Industry Trends Table 2. Next Generation AntiVirus Industry Drivers Table 3. Next Generation AntiVirus Industry Opportunities and Challenges Table 4. Next Generation AntiVirus Industry Restraints Table 5. Global Next Generation AntiVirus Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Next Generation AntiVirus Revenue Share by Company (2021-2026) Table 7. Global Next Generation AntiVirus Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Next Generation AntiVirus Key Company Manufacturing Base & Headquarters Table 9. Global Next Generation AntiVirus Company, Product Type & Application Table 10. Global Next Generation AntiVirus Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Next Generation AntiVirus by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Behavior and Event-Driven Table 15. Significant Companies of AI-Driven Table 16. Significant Companies of Others Table 17. Global Next Generation AntiVirus Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Next Generation AntiVirus Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Next Generation AntiVirus Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Next Generation AntiVirus Sales Value Share by Type (2021-2026) Table 21. Global Next Generation AntiVirus Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Finance and Insurance Table 23. Significant Companies of Manufacturing Table 24. Significant Companies of Internet and High Technology Table 25. Significant Companies of Others Table 26. Global Next Generation AntiVirus Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Next Generation AntiVirus Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Next Generation AntiVirus Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Next Generation AntiVirus Sales Value Share by Application (2021-2026) Table 30. Global Next Generation AntiVirus Sales Value Share by Application (2027-2032) Table 31. Global Next Generation AntiVirus Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Next Generation AntiVirus Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Next Generation AntiVirus Sales Value Share by Region (2021-2026) Table 34. Global Next Generation AntiVirus Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Next Generation AntiVirus Sales Value Share by Region (2027-2032) Table 36. Global Next Generation AntiVirus Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Next Generation AntiVirus Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Next Generation AntiVirus Sales Value Market Share by Country (2021-2026) Table 39. Global Next Generation AntiVirus Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Next Generation AntiVirus Sales Value Market Share by Country (2027-2032) Table 41. Microsoft Company Information Table 42. Microsoft Business Overview Table 43. Microsoft Next Generation AntiVirus Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Microsoft Next Generation AntiVirus Product Portfolio Table 45. Microsoft Recent Development Table 46. CrowdStrike Company Information Table 47. CrowdStrike Business Overview Table 48. CrowdStrike Next Generation AntiVirus Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. CrowdStrike Next Generation AntiVirus Product Portfolio Table 50. CrowdStrike Recent Development Table 51. Trend Micro Company Information Table 52. Trend Micro Business Overview Table 53. Trend Micro Next Generation AntiVirus Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Trend Micro Next Generation AntiVirus Product Portfolio Table 55. Trend Micro Recent Development Table 56. Trellix Company Information Table 57. Trellix Business Overview Table 58. Trellix Next Generation AntiVirus Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Trellix Next Generation AntiVirus Product Portfolio Table 60. Trellix Recent Development Table 61. Palo Alto Networks Company Information Table 62. Palo Alto Networks Business Overview Table 63. Palo Alto Networks Next Generation AntiVirus Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Palo Alto Networks Next Generation AntiVirus Product Portfolio Table 65. Palo Alto Networks Recent Development Table 66. Broadcom Company Information Table 67. Broadcom Business Overview Table 68. Broadcom Next Generation AntiVirus Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Broadcom Next Generation AntiVirus Product Portfolio Table 70. Broadcom Recent Development Table 71. Sophos Company Information Table 72. Sophos Business Overview Table 73. Sophos Next Generation AntiVirus Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Sophos Next Generation AntiVirus Product Portfolio Table 75. Sophos Recent Development Table 76. Bitdefender Company Information Table 77. Bitdefender Business Overview Table 78. Bitdefender Next Generation AntiVirus Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Bitdefender Next Generation AntiVirus Product Portfolio Table 80. Bitdefender Recent Development Table 81. Cisco Company Information Table 82. Cisco Business Overview Table 83. Cisco Next Generation AntiVirus Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Cisco Next Generation AntiVirus Product Portfolio Table 85. Cisco Recent Development Table 86. VMware Carbon Black Company Information Table 87. VMware Carbon Black Business Overview Table 88. VMware Carbon Black Next Generation AntiVirus Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. VMware Carbon Black Next Generation AntiVirus Product Portfolio Table 90. VMware Carbon Black Recent Development Table 91. Check Point Company Information Table 92. Check Point Business Overview Table 93. Check Point Next Generation AntiVirus Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Check Point Next Generation AntiVirus Product Portfolio Table 95. Check Point Recent Development Table 96. Malwarebytes Company Information Table 97. Malwarebytes Business Overview Table 98. Malwarebytes Next Generation AntiVirus Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Malwarebytes Next Generation AntiVirus Product Portfolio Table 100. Malwarebytes Recent Development Table 101. Fortinet Company Information Table 102. Fortinet Business Overview Table 103. Fortinet Next Generation AntiVirus Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Fortinet Next Generation AntiVirus Product Portfolio Table 105. Fortinet Recent Development Table 106. BlackBerry Cylance Company Information Table 107. BlackBerry Cylance Business Overview Table 108. BlackBerry Cylance Next Generation AntiVirus Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. BlackBerry Cylance Next Generation AntiVirus Product Portfolio Table 110. BlackBerry Cylance Recent Development Table 111. Research Programs/Design for This Report Table 112. Authors List of This Report Table 113. Secondary Sources Table 114. Primary Sources List of Figures Figure 1. Next Generation AntiVirus Product Image Figure 2. Global Next Generation AntiVirus Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Next Generation AntiVirus Market Size (2021-2032) & (US$ Million) Figure 4. Global Next Generation AntiVirus Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Behavior and Event-Driven Image Figure 8. AI-Driven Image Figure 9. Others Image Figure 10. Global Next Generation AntiVirus Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Next Generation AntiVirus Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Next Generation AntiVirus Sales Value Share by Type (2021-2032) Figure 13. Finance and Insurance Image Figure 14. Manufacturing Image Figure 15. Internet and High Technology Image Figure 16. Others Image Figure 17. Global Next Generation AntiVirus Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Next Generation AntiVirus Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Next Generation AntiVirus Sales Value Share by Application (2021-2032) Figure 20. Global Next Generation AntiVirus Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Next Generation AntiVirus Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Next Generation AntiVirus Sales Value (2021-2032) & (US$ Million) Figure 23. North America Next Generation AntiVirus Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Next Generation AntiVirus Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Next Generation AntiVirus Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Next Generation AntiVirus Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Next Generation AntiVirus Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Next Generation AntiVirus Sales Value (2021-2032) & (US$ Million) Figure 29. South America Next Generation AntiVirus Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Next Generation AntiVirus Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Next Generation AntiVirus Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Next Generation AntiVirus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Next Generation AntiVirus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Next Generation AntiVirus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Next Generation AntiVirus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Next Generation AntiVirus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Next Generation AntiVirus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Next Generation AntiVirus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Next Generation AntiVirus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Next Generation AntiVirus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Next Generation AntiVirus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Next Generation AntiVirus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Next Generation AntiVirus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Next Generation AntiVirus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Next Generation AntiVirus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Next Generation AntiVirus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Next Generation AntiVirus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Next Generation AntiVirus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Next Generation AntiVirus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Next Generation AntiVirus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Next Generation AntiVirus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Next Generation AntiVirus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Next Generation AntiVirus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Next Generation AntiVirus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Next Generation AntiVirus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Next Generation AntiVirus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Next Generation AntiVirus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Next Generation AntiVirus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Next Generation AntiVirus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Behavior and Event-Driven
  • AI-Driven
  • Others
Applications
  • Finance and Insurance
  • Manufacturing
  • Internet and High Technology
  • Others
Companies covered
  • Microsoft
  • CrowdStrike
  • Trend Micro
  • Trellix
  • Palo Alto Networks
  • Broadcom
  • Sophos
  • Bitdefender
  • Cisco
  • VMware Carbon Black
  • Check Point
  • Malwarebytes
  • Fortinet
  • BlackBerry Cylance

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Next Generation AntiVirus Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Next Generation AntiVirus Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Next Generation AntiVirus Market Dynamics
  1. 2.1 Next Generation AntiVirus Industry Trends
  2. 2.2 Next Generation AntiVirus Industry Drivers
  3. 2.3 Next Generation AntiVirus Industry Opportunities and Challenges
  4. 2.4 Next Generation AntiVirus Industry Restraints
3 Next Generation AntiVirus Market by Company
  1. 3.1 Global Next Generation AntiVirus Company Revenue Ranking in 2025
  2. 3.2 Global Next Generation AntiVirus Revenue by Company (2021-2026)
  3. 3.3 Global Next Generation AntiVirus Company Ranking (2024-2026)
  4. 3.4 Global Next Generation AntiVirus Company Manufacturing Base and Headquarters
  5. 3.5 Global Next Generation AntiVirus Company Product Type and Application
  6. 3.6 Global Next Generation AntiVirus Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Next Generation AntiVirus Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Next Generation AntiVirus Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Next Generation AntiVirus Market by Type
  1. 4.1 Next Generation AntiVirus Type Introduction
  2. 4.1.1 Behavior and Event-Driven
  3. 4.1.2 AI-Driven
  4. 4.1.3 Others
  5. 4.2 Global Next Generation AntiVirus Sales Value by Type
  6. 4.2.1 Global Next Generation AntiVirus Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Next Generation AntiVirus Sales Value by Type (2021-2032)
  8. 4.2.3 Global Next Generation AntiVirus Sales Value Share by Type (2021-2032)
5 Next Generation AntiVirus Market by Application
  1. 5.1 Next Generation AntiVirus Application Introduction
  2. 5.1.1 Finance and Insurance
  3. 5.1.2 Manufacturing
  4. 5.1.3 Internet and High Technology
  5. 5.1.4 Others
  6. 5.2 Global Next Generation AntiVirus Sales Value by Application
  7. 5.2.1 Global Next Generation AntiVirus Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Next Generation AntiVirus Sales Value by Application (2021-2032)
  9. 5.2.3 Global Next Generation AntiVirus Sales Value Share by Application (2021-2032)
6 Next Generation AntiVirus Regional Value Analysis
  1. 6.1 Global Next Generation AntiVirus Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Next Generation AntiVirus Sales Value by Region (2021-2032)
  3. 6.2.1 Global Next Generation AntiVirus Sales Value by Region: 2021-2026
  4. 6.2.2 Global Next Generation AntiVirus Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Next Generation AntiVirus Sales Value (2021-2032)
  7. 6.3.2 North America Next Generation AntiVirus Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Next Generation AntiVirus Sales Value (2021-2032)
  10. 6.4.2 Europe Next Generation AntiVirus Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Next Generation AntiVirus Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Next Generation AntiVirus Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Next Generation AntiVirus Sales Value (2021-2032)
  16. 6.6.2 South America Next Generation AntiVirus Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Next Generation AntiVirus Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Next Generation AntiVirus Sales Value Share by Country, 2025 VS 2032
7 Next Generation AntiVirus Country-level Value Analysis
  1. 7.1 Global Next Generation AntiVirus Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Next Generation AntiVirus Sales Value by Country (2021-2032)
  3. 7.2.1 Global Next Generation AntiVirus Sales Value by Country (2021-2026)
  4. 7.2.2 Global Next Generation AntiVirus Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Next Generation AntiVirus Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Next Generation AntiVirus Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Next Generation AntiVirus Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Next Generation AntiVirus Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Next Generation AntiVirus Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Next Generation AntiVirus Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Next Generation AntiVirus Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Next Generation AntiVirus Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Next Generation AntiVirus Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Next Generation AntiVirus Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Next Generation AntiVirus Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Next Generation AntiVirus Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Next Generation AntiVirus Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Next Generation AntiVirus Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Next Generation AntiVirus Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Next Generation AntiVirus Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Next Generation AntiVirus Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Next Generation AntiVirus Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Next Generation AntiVirus Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Next Generation AntiVirus Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Next Generation AntiVirus Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Next Generation AntiVirus Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Next Generation AntiVirus Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Next Generation AntiVirus Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Next Generation AntiVirus Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Next Generation AntiVirus Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Next Generation AntiVirus Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Next Generation AntiVirus Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Next Generation AntiVirus Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Next Generation AntiVirus Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Microsoft
  2. 8.1.1 Microsoft Company Information
  3. 8.1.2 Microsoft Business Overview
  4. 8.1.3 Microsoft Next Generation AntiVirus Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Microsoft Next Generation AntiVirus Product Portfolio
  6. 8.1.5 Microsoft Recent Developments
  7. 8.2 CrowdStrike
  8. 8.2.1 CrowdStrike Company Information
  9. 8.2.2 CrowdStrike Business Overview
  10. 8.2.3 CrowdStrike Next Generation AntiVirus Revenue and Gross Margin (2021-2026)
  11. 8.2.4 CrowdStrike Next Generation AntiVirus Product Portfolio
  12. 8.2.5 CrowdStrike Recent Developments
  13. 8.3 Trend Micro
  14. 8.3.1 Trend Micro Company Information
  15. 8.3.2 Trend Micro Business Overview
  16. 8.3.3 Trend Micro Next Generation AntiVirus Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Trend Micro Next Generation AntiVirus Product Portfolio
  18. 8.3.5 Trend Micro Recent Developments
  19. 8.4 Trellix
  20. 8.4.1 Trellix Company Information
  21. 8.4.2 Trellix Business Overview
  22. 8.4.3 Trellix Next Generation AntiVirus Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Trellix Next Generation AntiVirus Product Portfolio
  24. 8.4.5 Trellix Recent Developments
  25. 8.5 Palo Alto Networks
  26. 8.5.1 Palo Alto Networks Company Information
  27. 8.5.2 Palo Alto Networks Business Overview
  28. 8.5.3 Palo Alto Networks Next Generation AntiVirus Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Palo Alto Networks Next Generation AntiVirus Product Portfolio
  30. 8.5.5 Palo Alto Networks Recent Developments
  31. 8.6 Broadcom
  32. 8.6.1 Broadcom Company Information
  33. 8.6.2 Broadcom Business Overview
  34. 8.6.3 Broadcom Next Generation AntiVirus Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Broadcom Next Generation AntiVirus Product Portfolio
  36. 8.6.5 Broadcom Recent Developments
  37. 8.7 Sophos
  38. 8.7.1 Sophos Company Information
  39. 8.7.2 Sophos Business Overview
  40. 8.7.3 Sophos Next Generation AntiVirus Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Sophos Next Generation AntiVirus Product Portfolio
  42. 8.7.5 Sophos Recent Developments
  43. 8.8 Bitdefender
  44. 8.8.1 Bitdefender Company Information
  45. 8.8.2 Bitdefender Business Overview
  46. 8.8.3 Bitdefender Next Generation AntiVirus Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Bitdefender Next Generation AntiVirus Product Portfolio
  48. 8.8.5 Bitdefender Recent Developments
  49. 8.9 Cisco
  50. 8.9.1 Cisco Company Information
  51. 8.9.2 Cisco Business Overview
  52. 8.9.3 Cisco Next Generation AntiVirus Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Cisco Next Generation AntiVirus Product Portfolio
  54. 8.9.5 Cisco Recent Developments
  55. 8.10 VMware Carbon Black
  56. 8.10.1 VMware Carbon Black Company Information
  57. 8.10.2 VMware Carbon Black Business Overview
  58. 8.10.3 VMware Carbon Black Next Generation AntiVirus Revenue and Gross Margin (2021-2026)
  59. 8.10.4 VMware Carbon Black Next Generation AntiVirus Product Portfolio
  60. 8.10.5 VMware Carbon Black Recent Developments
  61. 8.11 Check Point
  62. 8.11.1 Check Point Company Information
  63. 8.11.2 Check Point Business Overview
  64. 8.11.3 Check Point Next Generation AntiVirus Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Check Point Next Generation AntiVirus Product Portfolio
  66. 8.11.5 Check Point Recent Developments
  67. 8.12 Malwarebytes
  68. 8.12.1 Malwarebytes Company Information
  69. 8.12.2 Malwarebytes Business Overview
  70. 8.12.3 Malwarebytes Next Generation AntiVirus Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Malwarebytes Next Generation AntiVirus Product Portfolio
  72. 8.12.5 Malwarebytes Recent Developments
  73. 8.13 Fortinet
  74. 8.13.1 Fortinet Company Information
  75. 8.13.2 Fortinet Business Overview
  76. 8.13.3 Fortinet Next Generation AntiVirus Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Fortinet Next Generation AntiVirus Product Portfolio
  78. 8.13.5 Fortinet Recent Developments
  79. 8.14 BlackBerry Cylance
  80. 8.14.1 BlackBerry Cylance Company Information
  81. 8.14.2 BlackBerry Cylance Business Overview
  82. 8.14.3 BlackBerry Cylance Next Generation AntiVirus Revenue and Gross Margin (2021-2026)
  83. 8.14.4 BlackBerry Cylance Next Generation AntiVirus Product Portfolio
  84. 8.14.5 BlackBerry Cylance Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst